Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Auxilium Pharmaceuticals, Inc. : and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents

05/24/2012 | 07:58am US/Eastern
Recommend:
0

MALVERN, Pa., and WILMINGTON, Del., May 24, 2012/PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc.; and Watson Pharma, Inc. (collectively, "Watson") for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's ("FDA's") Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the "Orange Book") as covering Testim® 1% testosterone gel.  The lawsuit was filed in the United States District Court for the District of New Jerseyon May 23, 2012.

Auxilium and FCB filed this lawsuit in response to a notice letter sent by Watson Laboratories, Inc. (NV) regarding its filing with the FDA of Abbreviated New Drug Application ("ANDA") No. 09

Recommend :
0
React to this article
Latest news on AUXILIUM PHARMACEUTICALS,
2d ago VIVUS : FDA Approves Stendra sNDA
6d ago AUXILIUM PHARMACEUTICALS : Endo Delivers A Proposal To Acquire Auxilium Pharmace..
6d ago AUXILIUM PHARMACEUTICALS : Responds To Unsolicited Proposal From Endo Internatio..
6d ago AUXILIUM PHARMACEUTICALS : Presents XIAFLEX CCH Data From MULTICORD And Retreatm..
6d ago VIVUS : And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First An..
7d ago Pending 'inversions' that new U.S. Treasury rules may hit
09/23 VIVUS : FDA Approves Stendra sNDA
09/22 AUXILIUM PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial..
09/22 AUXILIUM PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form..
09/22 AUXILIUM PHARMACEUTICALS : Endo International Comments On Auxilium Pharmaceutica..
Advertisement
Chart
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF